Fortis Healthcare Limited — Important, 17-01-2025: General Updates

Fortis Healthcare has significantly increased its stake in Agilus Diagnostics Limited, a material subsidiary, acquiring a total of 1,24,37,811 equity shares from NYLIM Jacob Ballas India Fund III LLC and 63,10,315 equity shares from Resurgence PE Investments Limited. This move boosts Fortis's ownership in Agilus to 89.2%, having previously acquired 5,970,149 shares from the International Finance Corporation. The increased shareholding (now totaling 31.52% from the private equity investors) may enhance Fortis's strategic influence over Agilus and improve its operational control. Investors should watch closely as this consolidation could lead to potential synergies and growth opportunities in diagnostics services.